NCT04894721View on ClinicalTrials.gov

Prophylaxis for COVID-19: Ivermectin in Close Contacts of COVID-19 Cases (IVERNEX-TUC)

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

172

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

September 30, 2021

Study Completion Date

October 1, 2021

Conditions
Covid19
Interventions
DRUG

Ivermectin

0,6mg/kg of weight orally on days 1 and 7

OTHER

Placebo

A substance with similar physical characteristics as ivermectin, without the active drug ingredient

Trial Locations (1)

4000

SI.PRO.SA, Ministerio de Salud Pública, San Miguel de Tucumán

All Listed Sponsors
lead

Ministry of Public Health, Argentina

OTHER_GOV